Pineapple Financial Inc. (PAPL)
NYSEAMERICAN: PAPL · Real-Time Price · USD
4.310
-0.830 (-16.15%)
Aug 1, 2025, 4:00 PM - Market closed
Revance Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Revance Therapeutics stock has a target of 5.00, which predicts a 16.01% increase from the current stock price of 4.31.
Price Target: $5.00 (+16.01%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 16, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Revance Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +16.01% | Apr 16, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +16.01% | Feb 27, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +16.01% | Jan 22, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5.5 → $5 | Strong Buy | Maintains | $5.5 → $5 | +16.01% | Jan 6, 2025 |
| EF Hutton | EF Hutton | Strong Buy Initiates $5.5 | Strong Buy | Initiates | $5.5 | +27.61% | May 29, 2024 |
Financial Forecast
Revenue This Year
2.88M
from 2.69M
Increased by 7.18%
Revenue Next Year
3.60M
from 2.88M
Increased by 25.02%
EPS This Year
-0.41
from -11.48
EPS Next Year
-0.21
from -0.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 3.0M | 3.7M |
| Avg | 2.9M | 3.6M |
| Low | 2.8M | 3.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 10.3% | 28.7% |
| Avg | 7.2% | 25.0% |
| Low | 3.0% | 20.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.42 | -0.22 |
| Avg | -0.41 | -0.21 |
| Low | -0.39 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.